22nd week of 2018 patent applcation highlights part 6 |
Patent application number | Title | Published |
20180147112 | LIQUID CIRCULATION MEMBER FOR MASSAGE DEVICE | 2018-05-31 |
20180147113 | CARDIOPULMONARY RESUSCITATION COORDINATION METHOD, COMPUTER PROGRAM PRODUCT AND SYSTEM | 2018-05-31 |
20180147114 | LITHIUM CONTAINING ALUMINOSILICATE GLASSES | 2018-05-31 |
20180147115 | LID COVER FOR MEDICINE CONTAINER | 2018-05-31 |
20180147116 | SYSTEM AND METHOD FOR PRODUCING A BAG FOR MEDICAL PURPOSES | 2018-05-31 |
20180147117 | Medical Device Connector | 2018-05-31 |
20180147118 | COMPOUNDING SYSTEMS AND METHODS FOR SAFE MEDICAMENT TRANSPORT | 2018-05-31 |
20180147119 | Robotic Capsule Filling Machine System | 2018-05-31 |
20180147120 | MODULAR MEDICATION DISPENSING SYSTEM | 2018-05-31 |
20180147121 | REMOTELY-EXECUTED MEDICAL THERAPY DEVICE | 2018-05-31 |
20180147122 | A CONTAINER GRIPPING AID | 2018-05-31 |
20180147123 | ENTERAL FEEDING PUMP SYSTEM | 2018-05-31 |
20180147124 | NON-INTRUSIVE BREAST MILK MONITORING | 2018-05-31 |
20180147125 | Low Water Dentifrice Compositions | 2018-05-31 |
20180147126 | COSMETICS | 2018-05-31 |
20180147127 | COSMETIC COMPOSITION | 2018-05-31 |
20180147128 | EMULSIONS FOR ENHANCED REDUCTIVE DECOLORATION OF KERATIN FIBERS | 2018-05-31 |
20180147129 | MILD COSMETIC CLEANING COMPOSITION WITH GOOD FOAM PROPERTIES | 2018-05-31 |
20180147130 | Topically Applied Cosmetic Reductive Composition Containing Keratin And Sulphur | 2018-05-31 |
20180147131 | COMPOSITION FOR ORAL CAVITY AND FOOD PRODUCT, OR BEVERAGE | 2018-05-31 |
20180147132 | ACTIVE-SUBSTANCE MIXTURES FOR STYLING AGENTS | 2018-05-31 |
20180147133 | COSMETIC COMPOSITIONS CONTAINING SILICONES | 2018-05-31 |
20180147134 | ANTI-CELL SENESCENCE COSMETIC COMPOSITION, USE OF CASEARIA SYLVESTRIS AND/OR HIMENAEA COURBARIL, METHOD OF PREVENTING CELL SENESCENCE AND A METHOD FOR MODULATING THE EXPRESSION OF B-GALACTOSIDASE, P16, P21 AND/OR IL-8 | 2018-05-31 |
20180147135 | COSMETIC COMPOSITIONS COMPRISING GINGER ROOT EXTRACTS | 2018-05-31 |
20180147136 | GENTIOPICROSIDE FREE GENTIANA EXTRACT | 2018-05-31 |
20180147137 | ANTIMICROBIAL COMPOSITIONS AND METHODS FOR REDUCING MICROBIAL CONTAMINATION | 2018-05-31 |
20180147138 | TRANSDERMAL LIQUID PREPARATION | 2018-05-31 |
20180147139 | INTRAVASCULAR DELIVERY OF NANOPARTICLE COMPOSITIONS AND USES THEREOF | 2018-05-31 |
20180147140 | Treatment and Prevention of ENT Infections | 2018-05-31 |
20180147141 | CHEWING GUM COMPOSITION COMPRISING CANNABINOIDS AND GABAPENTIN | 2018-05-31 |
20180147142 | METHOD FOR ISOLATION OF ALKALOIDS AND AMINO ACIDS, AND COMPOSITIONS CONTAINING ISOLATED ALKALOIDS AND AMINO ACIDS | 2018-05-31 |
20180147143 | LIQUID NALOXONE SPRAY | 2018-05-31 |
20180147144 | FOAMABLE FORMULATION | 2018-05-31 |
20180147145 | EPINEPHRINE NANOPARTICLES, METHODS OF FABRICATION THEREOF, AND METHODS FOR USE THEREOF FOR TREATMENT OF CONDITIONS RESPONSIVE TO EPINEPHRINE | 2018-05-31 |
20180147146 | DRY POWDER COMPOSITION COMPRISING LONG-CHAIN RNA | 2018-05-31 |
20180147147 | ORAL DELIVERY SYSTEM FOR BIOACTIVE AGENTS | 2018-05-31 |
20180147148 | PHARMACEUTICAL COMPOSITION OF TERIFLUNOMIDE | 2018-05-31 |
20180147150 | SUSTAINED RELEASE TABLET COMPRISING PREGABALIN THROUGH TWO-PHASE RELEASE-CONTROLLING SYSTEM | 2018-05-31 |
20180147151 | Pharmaceutical Formulation Containing Gelling Agent | 2018-05-31 |
20180147152 | RAPID DISSOLVE TABLET COMPOSITIONS FOR VAGINAL ADMINISTRATION | 2018-05-31 |
20180147153 | PROCESS FOR MAKING A COATED DOSAGE FORM | 2018-05-31 |
20180147154 | POLYVINYLPYRROLIDONE FOR THE STABILIZATION OF A SOLID DISPERSION OF THE NON-CRYSTALLINE FORM OF ROTIGOTINE | 2018-05-31 |
20180147155 | TRANSDERMAL DEVICE AND TRANSDERMAL PATCH | 2018-05-31 |
20180147156 | Therapeutic Compositions Comprising Monoterpenes | 2018-05-31 |
20180147157 | CANNABIDIOL FOR TREATMENT OF SEVERE AND REFRACTORY GRAFT-VERSUS-HOST DISEASE | 2018-05-31 |
20180147158 | DETOXIFYING ANTIMICROBIAL MOLECULAR COMPLEX | 2018-05-31 |
20180147159 | Astaxanthin Anti-Inflammatory Synergistic Combinations | 2018-05-31 |
20180147160 | Compositions for Use in Treating Parkinson's Disease and Related Disorders | 2018-05-31 |
20180147161 | MULTIDRUG BRITTLE MATRIX COMPOSITIONS | 2018-05-31 |
20180147162 | OPHTHALMIC COMPOSITIONS | 2018-05-31 |
20180147163 | COMBINATION COMPOSITIONS AND THEIR USE IN METHODS FOR TREATING OBESITY AND OBESITY-RELATED DISORDERS | 2018-05-31 |
20180147164 | 2-amino-N'-benzylideneacetohydrazides and Derivatives for the Management of CFTR Protein Mediated Diseases | 2018-05-31 |
20180147165 | METHODS FOR THE TREATMENT OF ROSACEA | 2018-05-31 |
20180147166 | BENZENE-1,3,5-TRICARBOXAMIDE DERIVATIVES AND USES THEREOF | 2018-05-31 |
20180147167 | METHODS AND COMPOSITIONS TO MODULATE THE GUT MICROBIOTA AND TO MANAGE WEIGHT | 2018-05-31 |
20180147168 | ANTIMICROBIALS AND METHODS OF USE THEREOF | 2018-05-31 |
20180147169 | PHARMACEUTICAL COMPOSITIONS AND THE TREATMENT OF OVERACTIVE BLADDER | 2018-05-31 |
20180147170 | ANTIHYPERTENSIVE AGENT | 2018-05-31 |
20180147171 | TRANS10:CIS12 ISOMER OF CONJUGATED LINOLEIC ACID AS A THERAPEUTIC AND PREVENTATIVE AGENT FOR HYPERTENSION SPECIFIC TO PREGNANCY | 2018-05-31 |
20180147172 | Compositions for Mitigating Head Trauma | 2018-05-31 |
20180147173 | COMPOSITIONS COMPRISING 15-HEPE AND METHODS OF TREATING OR PREVENTING CANCER AND NEUROLOGIC DISEASE | 2018-05-31 |
20180147174 | VITAMIN A FOR PARENTERAL ADMINSTRATION | 2018-05-31 |
20180147175 | COMPOSITIONS AND METHODS FOR TREATMENT OF MOVEMENT DISORDERS | 2018-05-31 |
20180147176 | COMPOSITION CONTAINING EICOSAPENTAENOIC ACID ALKYL ESTER, AND METHOD FOR PRODUCING SAME | 2018-05-31 |
20180147177 | Antibacterial Compositions Comprising Copper Oxo-Hydroxide Nanoparticles and Their Uses as Biocidal Agents | 2018-05-31 |
20180147178 | COMPOSITIONS AND METHODS TO IMPROVE THE THERAPEUTIC BENEFIT OF SUBOPTIMALLY ADMINISTERED CHEMICAL COMPOUNDS INCLUDING SUBSTITUTED HEXITOLS SUCH AS DIANHYDROGALACTITOL AND DIACETYLDIANHYDROGALACTITOL | 2018-05-31 |
20180147179 | CANNABINOID BLENDS AND FORMULATIONS, RELATED METHODS | 2018-05-31 |
20180147180 | DEVICES AND METHODS FOR FACILITATING AND CONTROLLING USE OF A MEDICATION | 2018-05-31 |
20180147181 | Use of andrographolide derivatives in preparation of medicaments for preventing and treating inflammatory bowel diseases | 2018-05-31 |
20180147182 | Breast cancer therapeutic agent containing 5'-hydroxy-5-nitro-indirubin-3'-oxime as active ingredient | 2018-05-31 |
20180147183 | USE OF R-OXIRACETAM IN PHARMACEUTICAL FIELD | 2018-05-31 |
20180147184 | BISAMIDE DERIVATIVE OF DICARBOXYLIC ACID AS AN AGENT FOR STIMULATING TISSUE REGENERATION AND RECOVERY OF DIMINISHED TISSUE FUNCTION | 2018-05-31 |
20180147185 | AUTOTAXIN INHIBITORS AND USES THEREOF | 2018-05-31 |
20180147186 | BENDAMUSTINE DERIVATIVES AND METHODS OF USING SAME | 2018-05-31 |
20180147187 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR INCREASING CFTR ACTIVITY | 2018-05-31 |
20180147188 | DOSING REGIMEN FOR A SELECTIVE S1P1 RECEPTOR AGONIST | 2018-05-31 |
20180147189 | ADMINISTRATION REGIMEN FOR THERAPEUTIC AGENTS FOR ATAXIA IN SPINOCEREBELLAR DEGENERATION | 2018-05-31 |
20180147190 | 3-(phenyl)-N-(4-phenoxybenzyl)-1,2,4-oxadiazole-5-carboxamide Compounds for the Management of CFTR Protein Mediated Diseases | 2018-05-31 |
20180147191 | COMPOUND USEFUL FOR THE TREATMENT OF NONSENSE-MUTATION-MEDIATED DISEASES AND PHARMACEUTICAL COMPOSITION COMPRISING SAID COMPOUND | 2018-05-31 |
20180147192 | PHARMACEUTICAL COMPOSITION OF MEK INHIBITOR AND PREPARATION METHOD THEREOF | 2018-05-31 |
20180147193 | Use of 4-Aminopyridine to Improve Neuro-Cognitive and/or Neuro-Psychiatric Impairment in Patients with Demyelinating and Other Nervous System Conditions | 2018-05-31 |
20180147194 | NOVEL COMPOUNDS AS REARRANGED DURING TRANSFECTION (RET) INHIBITORS | 2018-05-31 |
20180147195 | METHODS OF TREATING DEVELOPMENTAL DISORDERS USING PIPRADROL | 2018-05-31 |
20180147196 | PYRIDIN-3-YL ACETIC ACID DERIVATIVES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION | 2018-05-31 |
20180147197 | Chloroquine Induction of Par-4 and Treatment of Cancer | 2018-05-31 |
20180147198 | COMBINATIONS OF PFKFB3 INHIBITORS AND IMMUNE CHECKPOINT INHIBITORS TO TREAT CANCER | 2018-05-31 |
20180147199 | AQUEOUS LIQUID FORMULATION | 2018-05-31 |
20180147200 | METHOD OF INDUCING AUTOPHAGY | 2018-05-31 |
20180147202 | TANK-BINDING KINASE-1 PROTACs AND ASSOCIATED METHODS OF USE | 2018-05-31 |
20180147203 | CERDULATINIB FOR THE TREATMENT OF B-CELL MALIGNANCIES | 2018-05-31 |
20180147204 | STABLE AND SOLUBLE FORMULATIONS OF RECEPTOR TYROSINE KINASE INHIBITORS, AND METHODS OF PREPARATION THEREOF | 2018-05-31 |
20180147205 | Therapeutic Compositions | 2018-05-31 |
20180147206 | ACTIVATION OF NEURONAL STORE-OPERATED CALCIUM ENTRY PATHWAY FOR THE TREATMENT OF ALZHEIMER'S DISEASE | 2018-05-31 |
20180147207 | COMPOSITIONS AND METHODS FOR THERAPY OF PROSTATE CANCER USING DRUG COMBINATIONS TO TARGET POLYAMINE BIOSYNTHESIS AND RELATED PATHWAYS | 2018-05-31 |
20180147208 | IMIDAZO-PYRAZINYL DERIVATIVES USEFUL AS SOLUBLE GUANYLATE CYCLASE ACTIVATORS | 2018-05-31 |
20180147209 | PAR1 MODULATION TO ALTER MYELINATION | 2018-05-31 |
20180147210 | DOSING REGIMEN ASSOCIATED WITH LONG ACTING INJECTABLE PALIPERIDONE ESTERS | 2018-05-31 |
20180147211 | COMPOSITIONS AND METHODS FOR TREATING AN INFECTION | 2018-05-31 |
20180147212 | COMPOSITIONS AND METHODS FOR TREATING AN INFECTION | 2018-05-31 |
20180147213 | METHODS OF COSMETICALLY TREATING SKIN CONDITIONS WITH A COSMETIC PERSONAL CLEANSING COMPOSITION | 2018-05-31 |